Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Business of Quality: Evaluating the Impact of Healthcare Quality Improvements on Staff Numbers and Patient Utilization in Sub-Saharan Africa

Gloria P. Gómez-Pérez, Daniëlla Brals, Aafke E. de Graaff, Ibironke Dada, Bonifacia Benefo Agyei, Peter Risha, Elizabeth Bonareri, John T. Dekker, Tobias F. Rinke de Wit, Nicole Spieker, Wendy Janssens
doi: https://doi.org/10.1101/2023.02.03.23285375
Gloria P. Gómez-Pérez
1PharmAccess Foundation, Amsterdam, The Netherlands
2Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniëlla Brals
2Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
3Department of Global Health, Amsterdam UMC, University of Amsterdam, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aafke E. de Graaff
1PharmAccess Foundation, Amsterdam, The Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ibironke Dada
4PharmAccess Nigeria, Lagos, Nigeria
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonifacia Benefo Agyei
5PharmAccess Ghana, Accra, Ghana
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Risha
6PharmAccess Tanzania, Dar es Salaam, Tanzania
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Bonareri
7PharmAccess Kenya, Nairobi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John T. Dekker
1PharmAccess Foundation, Amsterdam, The Netherlands
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias F. Rinke de Wit
1PharmAccess Foundation, Amsterdam, The Netherlands
2Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Spieker
1PharmAccess Foundation, Amsterdam, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Janssens
2Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
8Faculty of Economics, Vrije Universiteit, Amsterdam, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: w.janssens@vu.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Every year an estimated 5 to 8 million people die in low- and middle-income countries (LMICs) due to poor-quality care. Although quality improvements in healthcare facilities in LMICs are well-possible with tailored implementation plans, costs are often mentioned as a prohibiting factor. However, if quality improvements increase trust among patients, this might translate into increased visits and higher revenues for providers and enable them to further invest in quality. This paper assesses the potential business case of quality improvements in Sub-Saharan Africa (SSA). It focuses on both the public and private sector since the latter provides at least half of all health services in SSA. The analysis is based on a dataset including multiple assessments of quality and business performance indicators for almost 500 health facilities in Tanzania, Kenya, Ghana, Nigeria, and other SSA-countries. We studied the association between changes in quality assessment scores and subsequent changes in numbers of patient visits and staff as proxies for business growth. We found that quality improvements significantly improved business performance indicators, but only for those facilities that had already reached a certain level of quality to begin with. These findings suggest an S-shaped relationship between quality and business performance, leading to the existence of a ‘low-quality trap’. Substantial financial investments might be needed initially to support facilities at the bottom of the distribution in reaching a basic level of quality, after which further quality investments may start translating into increased revenues, enhancing business performance.

Key messages

  • Millions of people die every year in low- and middle-income countries (LMICs) due to low quality of care

  • To reach Universal Health Coverage, drastic quality improvements are essential

  • Achieving quality of care in LMICs is possible but challenging because it requires substantial financial investments, specialized skills and sufficient human resources

  • We found there is a business case for quality investments in SSA, as quality improvements are associated with a significant increase in the number of patient visits and staff over time, indicative of greater revenue streams and financial capacity

  • Targeted financing programmes together with technical assistance to healthcare facilities are critical to drive quality investments, especially for facilities at the beginning of their quality improvement journeys

Competing Interest Statement

Some authors are current employees of PharmAccess Foundation, an institution discussed in this article. These affiliations are explicitly listed in the article.

Funding Statement

This work was supported by the Health Insurance Fund of the Minister of Foreign Affairs of The Netherlands.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† These authors are joint last authors

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 07, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Business of Quality: Evaluating the Impact of Healthcare Quality Improvements on Staff Numbers and Patient Utilization in Sub-Saharan Africa
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Business of Quality: Evaluating the Impact of Healthcare Quality Improvements on Staff Numbers and Patient Utilization in Sub-Saharan Africa
Gloria P. Gómez-Pérez, Daniëlla Brals, Aafke E. de Graaff, Ibironke Dada, Bonifacia Benefo Agyei, Peter Risha, Elizabeth Bonareri, John T. Dekker, Tobias F. Rinke de Wit, Nicole Spieker, Wendy Janssens
medRxiv 2023.02.03.23285375; doi: https://doi.org/10.1101/2023.02.03.23285375
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The Business of Quality: Evaluating the Impact of Healthcare Quality Improvements on Staff Numbers and Patient Utilization in Sub-Saharan Africa
Gloria P. Gómez-Pérez, Daniëlla Brals, Aafke E. de Graaff, Ibironke Dada, Bonifacia Benefo Agyei, Peter Risha, Elizabeth Bonareri, John T. Dekker, Tobias F. Rinke de Wit, Nicole Spieker, Wendy Janssens
medRxiv 2023.02.03.23285375; doi: https://doi.org/10.1101/2023.02.03.23285375

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Systems and Quality Improvement
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1968)
  • Dentistry and Oral Medicine (253)
  • Dermatology (188)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11128)
  • Forensic Medicine (8)
  • Gastroenterology (631)
  • Genetic and Genomic Medicine (3204)
  • Geriatric Medicine (310)
  • Health Economics (568)
  • Health Informatics (2054)
  • Health Policy (864)
  • Health Systems and Quality Improvement (792)
  • Hematology (311)
  • HIV/AIDS (686)
  • Infectious Diseases (except HIV/AIDS) (12750)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (319)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3005)
  • Nursing (167)
  • Nutrition (466)
  • Obstetrics and Gynecology (591)
  • Occupational and Environmental Health (614)
  • Oncology (1566)
  • Ophthalmology (478)
  • Orthopedics (189)
  • Otolaryngology (267)
  • Pain Medicine (204)
  • Palliative Medicine (57)
  • Pathology (404)
  • Pediatrics (916)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (357)
  • Psychiatry and Clinical Psychology (2811)
  • Public and Global Health (5620)
  • Radiology and Imaging (1104)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (765)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (291)
  • Surgery (351)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)